Yuwei Liu1, Shengcai Wang1, Yanzhen Li1, Xuexi Zhang1, Zhiyong Liu1, Qiaoyin Liu1, Nian Sun1, Jie Zhang1, Wentong Ge1, Yongli Guo2, Yuanhu Liu1, Xiaolian Fang1, Tingting Ji1, Jun Tai3, Xin Ni1,2. 1. Department of Otolaryngology, Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health (NCCH), Beijing, China. 2. Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health (NCCH), Beijing, China. 3. Children's Hospital Capital Institute of Pediatrics, Department of Otolaryngology, Head and Neck Surgery, Beijing, China.
Abstract
OBJECTIVES: The objectives of this study were to explore the clinical heterogeneity of differentiated thyroid cancer (DTC) between prepubertal children and adolescents and guide clinical treatment. METHODS: A retrospective study included patients with DTC aged ≤19 years in Beijing Children's Hospital from June 2014 to June 2019. All patients were enrolled and divided into 2 subgroups based on the threshold age of 10 years, namely the childhood group (CG) (≤10 years old); and the adolescent group (AG) (between 10 and 19 years old). The χ2 test and Fisher's exact test were used to estimate the effect of risk factors in the 2 age groups. Multivariate binary logistic regression models were conducted to assess the recurrent risk factors. RESULTS: Seventy cases of DTC were included with an average age of 9.94 ± 2.88 years, including 35 in CG and 35 in AG. The most common clinical manifestation was a painless mass in the neck, accounting for 77.1% (54/70) of patients. Compared with the AG, the CG was more likely to have lymph node metastasis (p = 0.022) and distant metastasis (p = 0.041). The CG was more likely to have extrathyroidal extension (p = 0.012) and had a significantly higher recurrence rate than the AG (p = 0.040). Age was an independent variable predictive of recurrence (p = 0.0347). CONCLUSION: Regional invasiveness, cervical lymph node metastasis, and distant metastasis of DTC were more likely to occur in children ≤10 years old. Meanwhile, children ≤10 years old with DTC were more likely to have recurrence than adolescent's postsurgical treatment. Thus, children younger than 10 years of age with DTC should be treated more aggressively.
OBJECTIVES: The objectives of this study were to explore the clinical heterogeneity of differentiated thyroid cancer (DTC) between prepubertal children and adolescents and guide clinical treatment. METHODS: A retrospective study included patients with DTC aged ≤19 years in Beijing Children's Hospital from June 2014 to June 2019. All patients were enrolled and divided into 2 subgroups based on the threshold age of 10 years, namely the childhood group (CG) (≤10 years old); and the adolescent group (AG) (between 10 and 19 years old). The χ2 test and Fisher's exact test were used to estimate the effect of risk factors in the 2 age groups. Multivariate binary logistic regression models were conducted to assess the recurrent risk factors. RESULTS: Seventy cases of DTC were included with an average age of 9.94 ± 2.88 years, including 35 in CG and 35 in AG. The most common clinical manifestation was a painless mass in the neck, accounting for 77.1% (54/70) of patients. Compared with the AG, the CG was more likely to have lymph node metastasis (p = 0.022) and distant metastasis (p = 0.041). The CG was more likely to have extrathyroidal extension (p = 0.012) and had a significantly higher recurrence rate than the AG (p = 0.040). Age was an independent variable predictive of recurrence (p = 0.0347). CONCLUSION: Regional invasiveness, cervical lymph node metastasis, and distant metastasis of DTC were more likely to occur in children ≤10 years old. Meanwhile, children ≤10 years old with DTC were more likely to have recurrence than adolescent's postsurgical treatment. Thus, children younger than 10 years of age with DTC should be treated more aggressively.
Authors: Neil K Jain; Sogol Mostoufi-Moab; Colin P Hawkes; Nya D Nelson; Lea F Surrey; Zachary S Jones; N Scott Adzick; Ken Kazahaya; Andrew J Bauer Journal: Thyroid Date: 2019-10-01 Impact factor: 6.568
Authors: Stefan Scholz; Jessica R Smith; Beverly Chaignaud; Robert C Shamberger; Stephen A Huang Journal: J Pediatr Surg Date: 2011-03 Impact factor: 2.545
Authors: Daria Handkiewicz-Junak; Jan Wloch; Jozef Roskosz; Jolanta Krajewska; Aleksandra Kropinska; Lech Pomorski; Aleksandra Kukulska; Andrzej Prokurat; Zbigniew Wygoda; Barbara Jarzab Journal: J Nucl Med Date: 2007-06 Impact factor: 10.057
Authors: Yuri E Demidchik; Eugene P Demidchik; Christoph Reiners; Johannes Biko; Mariko Mine; Vladimir A Saenko; Shunichi Yamashita Journal: Ann Surg Date: 2006-04 Impact factor: 12.969
Authors: Maria Isabel Cunha Vieira Cordioli; Lais Moraes; Maria Teresa de Seixas Alves; Rosana Delcelo; Osmar Monte; Carlos Alberto Longui; Adriano Namo Cury; Janete Maria Cerutti Journal: Int J Endocrinol Date: 2016-02-28 Impact factor: 3.257